And then, STING-/- mice or topical application of C-176 (96), a STING inhibitor, will be used to assess the corneal fluorescein staining and number of goblet cells, which will provide evidence for the therapeutic potential by inhibiting cGAS-STING pathway in dry eye. The gene discussed is CGAS; the disease is Keratoconjunctivitis sicca.